Update: The text of Wayne Mapp’s speech has now been posted on the Beehive web site.
Dr Wayne Mapp is the Minister of Science, Research and Technology, as well as an Associate Minister of Economic Development and Tertiary Education. The synergy between these portfolios mean that Dr Mapp should be in a good position to encourage the various parts of the innovation sector to work together to spur economic growth.
Dr Mapp spoke at a New Zealand Venture Capital Association and Angel Association gathering last week at NZX, discussing the importance of early-stage investment. He believes that the current innovation system is overly complex, and that simplification will allow the system to “power up” and attain critical mass. He says that science is at the forefront of the government’s growth strategy, and to expect a number of announcements in the coming months in this area.
Key points:
Government priorities for $750m spent on science:
Primary sector – but it’s hard to get high growth out of the agricultural sector
CRI’s
They need clearer missions
CRI funding needs to be more sustainable
The CRI’s should have a clearer sense of accountability to the sectors they serve
Marsden fund – fundamental science
Health Research Council
TechNZ – $50m – there is a huge opportunity to upgrade the brand of TechNZ and to make it the principle vehicle of government funding of business in science
A key challenge is to provide a clear architecture of the linkages between TechNZ, NZVIF and NZTE.
The government is commited to making the transformational decisions that will make that $750m [in science] expenditure more effective, easier to access, and more valuable to our country. The ultimate goal is to be able to say that this [NZ] is the place to do business, this is the place of innovation, this is the place of growth for the future.
Shout it from the rooftops – there’s going to be an IPO! It would appear that rumours of the death of the IPO have been greatly exaggerated.
The last start-up IPOs in New Zealand were in the class of 2007 – Xero, Burgerfuel, and NZ Farming Systems Uruguay; I’d argue that Burgerfuel probably didn’t belong in that class, and that NZFSU was more of a property play than an intellectual property play. Xero is the standout, and have deservedly done well after a hard slog.
Biovittoria’s IPO offers angel investors a lot of hope that it’s still possible to take great ideas through the investment cycle and come out the other end as a listed company. With backing by Endeavour Capital, ACC, Stephen Tindall’s K1W1 and the NZ Venture Investment Fund (NZVIF) they’ve managed to bring their product to the point where it’s ready for true international expansion.
Biovittoria appear to be in a great position to exploit their market, with exclusive rights the key ingredient in their PureLo artificial sweetener product. PureLo was the first natural sweetener of its type to achieve United States Food and Drug Administration (FDA) regulatory compliance through its Generally Recognised As Safe (GRAS) status. They expect full FDA approval in February next year. The global artificial sweetener market is worth over USD 3.5 Billion.
This week’s launch of AngelLink could mark a pivotal moment in the development of New Zealand’s innovation space.
Conceived and managed by WaikatoLink, AngelLink is a new national angel investment network specifically designed to commercialise intellectual property from universities and CRI’s, and is backed by the country’s most experienced and well-resourced hi-tech and biotech investors.
It brings New Zealand angel investment to the next level.
This is exciting news for a number of reasons:
Movac, K1W1, Sparkbox, Neville Jordan, Waikato University, AUT, and SCIF are coming together to actively collaborate. While these players have co-invested with each other on a tactical basis before, this is the first time they’ve all agreed to work together in a more formal, strategic framework.
Research institutions generate considerable intellectual property that until now has never seen the light of day, due to limited resources and commercialisation experience in the niche investment spaces and geographic locations that they occupy. A national network will increase the likelihood of successful commercialisation of some of New Zealand’s best IP.
Conversely, angel investors nationwide have had limited access to university-sourced IP. AngelLink will give access to opportunities to a wider group of experienced investors.
The common theme is that all of the stakeholders – inventors, entrepreneurs, incubators, investors, and government – all understand that there are huge gains to be realised by working together, and have the appetite to make it happen. People realise that the pie can be made disproportionately bigger by relinquishing some ownership and control.
There’s a word for that – maturity.
And the experience and professionalism is evident from the start. AngelLink achieved SCIF accreditation prior to launch. Although based in the Waikato, they chose to launch at NZX in Wellington to underscore the national nature of the network. AngelLink is not a small club of wealthy dentists and farmers. At the launch, Chris de Boer, AngelLink’s chairman, said that he’d never seen such a broad spectrum of New Zealand investors in one room, ever. The gathering included people like Wayne Mapp (Minister of Science Research and Technology), Mark Weldon (CEO NZX), Franceska Banga (CEO NZVIF), Sir John Anderson (Chancellor Waikato University), Jim Bolger (Chairman NZ Post), Neville Jordan (Endeavour Capital), Mark Stuart (CEO WaikatoLink), Greg Sitters (Sparkbox), Phil McCaw and David Beard (Movac), Suse Reynolds (Angel HQ), John Errington (CEO VicLink), as well as a number of familiar faces from the local Wellington angel scene. Exposure to the entire investment food chain is compelling.
Chris said that they already have pipeline with four deals ready to go on day one.
There is some potential risk in setting up a new national angel network that has some overlap with the existing regional clubs. Some of New Zealand’s fledgling angel clubs are struggling to achieve and maintain critical mass, both in terms of investment capacity and ability to attract quality opportunities. But that shouldn’t be a problem so long as AngelLink sticks to institutional IP, and doesn’t compete with clubs for deals coming from local incubators and garage entrepreneurs. Syndication is all about sharing expertise, resources, risk and reward in such a way that everyone benefits.
And if AngelLink continues in the same manner as it has started, everyone will benefit from commercialising previously hidden IP.